Crescita Therapeutics Inc.
CRRTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $6 | $11 | $12 |
| - Cash | $8 | $8 | $9 | $9 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $1 | -$1 | $3 | $4 |
| Revenue | $5 | $6 | $4 | $7 |
| % Growth | -13.5% | 76.2% | -48.8% | – |
| Gross Profit | $3 | $4 | $2 | $3 |
| % Margin | 52.9% | 61.4% | 49.4% | 43.4% |
| EBITDA | $1 | $1 | -$1 | $0 |
| % Margin | 21.3% | 18.7% | -16% | 3% |
| Net Income | $1 | $1 | -$1 | -$0 |
| % Margin | 14% | 12.8% | -26.4% | -2.3% |
| EPS Diluted | 0.04 | 0.04 | -0.05 | -0.008 |
| % Growth | 0% | 180% | -495.2% | – |
| Operating Cash Flow | $1 | -$0 | -$1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | -$0 | -$1 | $1 |